{"id":"W4402097645","doi":"10.1016/j.kint.2024.08.023","title":"A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease","year":2024,"lang":"en","type":"article","venue":"Kidney International","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); McMaster University; Université Laval; Bioinformatics Solutions (Canada); Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; Centre hospitalier de l'Université Laval","funders":"CSL Behring; Alexion Pharmaceuticals; Novo Nordisk; Sanofi; Pfizer; AstraZeneca; Eli Lilly and Company; Vifor Pharma; Hispanic Scholarship Consortium","keywords":"Medicine; Agonist; Internal medicine; Glucagon-like peptide 1 receptor; Renal function; Endocrinology; Kidney disease; Glucagon; Kidney; Diabetes mellitus; Glucagon-like peptide-1; Urology; Type 2 diabetes; Receptor; Insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003678267,0.0003153765,0.0005627932,0.0002181941,0.00007377259,0.0001061658,0.0002459764,0.0000501223,0.0001687371],"category_scores_gemma":[0.003465599,0.0001546136,0.0002564806,0.0002078276,0.0002796586,0.0001168508,0.0001230174,0.0001983566,0.00002084839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001739456,"about_ca_system_score_gemma":0.000331336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000040874,"about_ca_topic_score_gemma":0.000002524168,"domain_scores_codex":[0.9979165,0.0002102094,0.0004629678,0.0004114689,0.0007398123,0.0002591021],"domain_scores_gemma":[0.9981741,0.0007090165,0.0001579485,0.0003902337,0.00008513786,0.0004835181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.676134,0.008275325,0.1238961,0.001472509,0.006368964,0.00007808608,0.001228977,0.000003642683,0.0003901493,0.00502087,0.1724622,0.004669099],"study_design_scores_gemma":[0.9174055,0.001517541,0.03382395,0.002736529,0.001609154,5.08712e-7,0.00002421603,0.0007234336,0.0009273368,0.0002178744,0.04073674,0.0002772332],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9717911,0.00008222206,0.00001620639,0.01841225,0.003432296,0.004268398,0.0003338481,0.00005694483,0.001606693],"genre_scores_gemma":[0.9835671,0.0000490077,0.00006031304,0.006708488,0.0001690613,0.0006423122,0.0007061437,0.000040835,0.008056743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2412714,"threshold_uncertainty_score":0.630496,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006374980941605441,"score_gpt":0.2530584322524269,"score_spread":0.2466834513108215,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}